Recherche
-
ChatGPT and beyond with artificial intelligence (AI) in health: Lessons to be learned.
(Joint Bone Spine. vol. 90, n° 5, pp. 105607, 2023-09-01)Article de revue -
ChatGPT et au-delà avec l’intelligence artificielle en santé : des leçons à tirer
(Revue du Rhumatisme. vol. 91, n° 1, pp. 12-15, 2024-01-01)Article de revue -
Random survival forests with multivariate longitudinal endogenous covariates
(Statistical Methods in Medical Research. vol. 32, n° 12, pp. 2331-2346, 2023-12-01)Article de revueLibre accès -
Robust and Efficient Optimization Using a Marquardt-Levenberg Algorithm with R Package marqLevAlg
(R Journal. vol. 13, n° 2, pp. 365-379, 2021-12)Article de revueLibre accès -
SAMBA: a Novel Method for Fast Automatic Model Building in Nonlinear Mixed-Effects Models
(CPT: Pharmacometrics and Systems Pharmacology. vol. 11, n° 2, pp. 161-172, 2022-02)Article de revueLibre accès -
Acute respiratory distress syndrome after SARS-CoV-2 infection on young adult population: International observational federated study based on electronic health records through the 4CE consortium
(PLoS ONE. vol. 18, n° 1, pp. e0266985, 2023-04-05)Article de revueLibre accès -
Development and external validation of a prediction model for the transition from mild to moderate or severe form of COVID-19
(European Radiology, 2023-07-05)Article de revueLibre accès -
Public Health surveillance from emergency call center data: visualization dashboard and NLP of call reports: Public Health surveillance from EMCC data
(The International FLAIRS Conference Proceedings, FLAIRS-35 - 35th International Florida Artificial Intelligence Research Society Conference, us, Hutchinson, 2022-05-04)Communication dans un congrès avec actesLibre accès -
Cohort Profile: International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)
(International Journal of Epidemiology. vol. 53, n° 1, 2024-02-01)Article de revueLibre accès -
Immunogenicity and vaccine shedding after 1 or 2 doses of rVZVDeltaG-ZEBOV-GP Ebola vaccine (ERVEBO(R)): Results from a phase 2, randomized, placebo-controlled trial in children and adults
(Clinical Infectious Diseases, 2023-11-15)Article de revueLibre accès